Jun-Sheng Wang

799 total citations
13 papers, 632 citations indexed

About

Jun-Sheng Wang is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Jun-Sheng Wang has authored 13 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 8 papers in Oncology and 6 papers in Psychiatry and Mental health. Recurrent topics in Jun-Sheng Wang's work include Pharmacological Effects and Toxicity Studies (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pregnancy and Medication Impact (5 papers). Jun-Sheng Wang is often cited by papers focused on Pharmacological Effects and Toxicity Studies (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pregnancy and Medication Impact (5 papers). Jun-Sheng Wang collaborates with scholars based in United States, China and Germany. Jun-Sheng Wang's co-authors include C. Lindsay DeVane, Hao‐Jie Zhu, John S. Markowitz, Jennifer L. Donovan, Bryan B. Gibson, Holly A. Gefroh, Zachary N. Stowe, D. Jeffrey Newport, Page B. Pennell and Kennerly S. Patrick and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Jun-Sheng Wang

13 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun-Sheng Wang United States	13	215	199	194	185	86	13	632
Heidi L. Liston United States	10	194 0.9×	183 0.9×	258 1.3×	126 0.7×	54 0.6×	12	712
Bryan B. Gibson United States	8	155 0.7×	95 0.5×	137 0.7×	167 0.9×	61 0.7×	9	637
Ryan Z. Turncliff United States	18	232 1.1×	361 1.8×	191 1.0×	181 1.0×	171 2.0×	24	1.1k
Rita Labroo United States	11	140 0.7×	73 0.4×	89 0.5×	143 0.8×	63 0.7×	13	765
Louis L. Radulovic United States	16	219 1.0×	121 0.6×	224 1.2×	128 0.7×	171 2.0×	25	973
C. Alm Sweden	12	129 0.6×	123 0.6×	185 1.0×	152 0.8×	53 0.6×	15	764
Robert A. Ronfeld United States	18	148 0.7×	150 0.8×	89 0.5×	236 1.3×	90 1.0×	29	1.0k
Siu Wah Cheung Canada	12	134 0.6×	90 0.5×	150 0.8×	221 1.2×	165 1.9×	13	889
Tore Haslemo Norway	19	221 1.0×	124 0.6×	461 2.4×	192 1.0×	48 0.6×	37	919
Katrin M. Kirschbaum Germany	13	116 0.5×	79 0.4×	204 1.1×	80 0.4×	77 0.9×	19	511

Countries citing papers authored by Jun-Sheng Wang

Since Specialization

Citations

This map shows the geographic impact of Jun-Sheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Sheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Sheng Wang more than expected).

Fields of papers citing papers by Jun-Sheng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Sheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Sheng Wang. The network helps show where Jun-Sheng Wang may publish in the future.

Co-authorship network of co-authors of Jun-Sheng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-Sheng Wang. A scholar is included among the top collaborators of Jun-Sheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-Sheng Wang. Jun-Sheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Jun-Sheng, Hao‐Jie Zhu, Jennifer L. Donovan, et al.. (2009). Aripiprazole brain concentration is altered in P-glycoprotein deficient mice. Schizophrenia Research. 110(1-3). 90–94. 30 indexed citations

Wang, Jun-Sheng, et al.. (2008). Sertraline and Its Metabolite Desmethylsertraline, but not Bupropion or Its Three Major Metabolites, Have High Affinity for P-Glycoprotein. Biological and Pharmaceutical Bulletin. 31(2). 231–234. 54 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, Jennifer L. Donovan, et al.. (2007). Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein. European Journal of Pharmacology. 578(2-3). 148–158. 25 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, Kennerly S. Patrick, et al.. (2007). A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma. Journal of Chromatography B. 858(1-2). 91–95. 31 indexed citations

Wang, Jun-Sheng, D. Jeffrey Newport, Zachary N. Stowe, et al.. (2007). The Emerging Importance of Transporter Proteins in the Psychopharmacological Treatment of the Pregnant Patient. Drug Metabolism Reviews. 39(4). 723–746. 26 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, C. Lindsay DeVane, et al.. (2006). THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE. Drug Metabolism and Disposition. 34(7). 1116–1121. 16 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, John S. Markowitz, et al.. (2006). Risperidone and Paliperidone Inhibit P-Glycoprotein Activity In Vitro. Neuropsychopharmacology. 32(4). 757–764. 77 indexed citations

Zhu, Hao‐Jie, Jun-Sheng Wang, Jennifer L. Donovan, et al.. (2006). Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization. Journal of Chromatography B. 846(1-2). 351–354. 34 indexed citations

Wang, Jun-Sheng, Hao‐Jie Zhu, John S. Markowitz, Jennifer L. Donovan, & C. Lindsay DeVane. (2006). Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology. 187(4). 415–423. 105 indexed citations

10.

Zhu, Hao‐Jie, Jun-Sheng Wang, John S. Markowitz, et al.. (2006). Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana. Journal of Pharmacology and Experimental Therapeutics. 317(2). 850–857. 140 indexed citations

11.

DeVane, C. Lindsay, Zachary N. Stowe, Jennifer L. Donovan, et al.. (2006). Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities. Journal of Psychopharmacology. 20(4_suppl). 54–59. 34 indexed citations

12.

Wang, Jun-Sheng, C. Lindsay DeVane, Bryan B. Gibson, et al.. (2005). Population pharmacokinetic analysis of drug–drug interactions among risperidone, bupropion, and sertraline in CF1 mice. Psychopharmacology. 183(4). 490–499. 40 indexed citations

13.

Zhu, Hao‐Jie, et al.. (2005). Reversal of P-Glycoprotein Mediated Multidrug Resistance in K562 Cell Line by a Novel Synthetic Calmodulin Inhibitor, E6. Biological and Pharmaceutical Bulletin. 28(10). 1974–1978. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact